Serina Therapeutics (SER) executive Moreadith sold 3,555 shares for $11.5K at $3.24
Insider transactions reported
Randall Moreadith (Chief Scientific Officer at Serina Therapeutics Inc., SER) reported that they sold 3,555 shares for $11.5K at $3.24, and acquired 3,555 shares at $0.06 on Dec 11, 2025. After these transactions the filing shows 0 shares held directly.
- Reporting person
- Moreadith Randall
- Role
- Chief Scientific Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | Exercise or conversion of a derivative (M) | Common Stock | +3,555 | $0.06 | $213 | 3,555 direct |
| Dec 11, 2025 | Open-market sale (S) | Common Stock1 | -3,555 | $3.24 | $11.5K | 0 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | Exercise or conversion of a derivative (M) | Stock Option (right to buy)On 3,555 Common Stock2 | -3,555 | - | - | 366,886 direct |
Holdings before and after
- Stock Option (right to buy): 370,441 to 366,886 direct
Footnotes from the filing
- 1. The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.35. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- 2. The stock options are fully vested.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Moreadith report in this SER Form 4?
Randall Moreadith (Chief Scientific Officer at Serina Therapeutics Inc., SER) reported that they sold 3,555 shares for $11.5K at $3.24, and acquired 3,555 shares at $0.06 on Dec 11, 2025. After these transactions the filing shows 0 shares held directly.
How many SER shares does Moreadith hold after this filing?
The filing shows 0 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this SER insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for SER
Across the 4 sessions after earlier SER headlines, the stock closed higher 0 times and lower 4 times, with a median move of 2.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | SER | SPY |
|---|---|---|---|
| Dec 12, 2025 | Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry | -0.6% | -1.1% |
| Dec 11, 2025 | Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program | -2.2% | +0.2% |
| Nov 13, 2025 | Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights | -2.5% | -1.7% |
| Nov 3, 2025 | Serina Therapeutics Provides Regulatory Update on SER-252 Program | -6.4% | +0.2% |
Earlier insider filings at SER
- Dec 11, 2025Chief Scientific Officer Moreadith Randall exercised 600 shares at a strike of $0.06, sold $4,149 worth of shares (1,245 units at $3.33) and was granted 645 shares (SEC Form 4)
- Dec 5, 2025Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $23,481 worth of shares (6,500 units at $3.61) (SEC Form 4)
- Nov 26, 2025Chief Scientific Officer Moreadith Randall exercised 5,965 shares at a strike of $0.06 and sold $23,264 worth of shares (5,965 units at $3.90) (SEC Form 4)
- Nov 26, 2025Chief Scientific Officer Moreadith Randall sold $2,105 worth of shares (535 units at $3.93) and exercised 535 shares at a strike of $0.06 (SEC Form 4)
- Nov 19, 2025Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $24,402 worth of shares (6,500 units at $3.75) (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Follow SER and get a push notification the moment its next story breaks.